MedPath

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

Recruiting
Conditions
Smoking, Cigarette
Tobacco Use
Tobacco Smoking
Smoking, Tobacco
Alcohol Drinking
Betel Chewer's Mucosa
Smoking
Smokeless Tobacco Hyperkeratosis
Interventions
Diagnostic Test: mHealth
Registration Number
NCT06535867
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5122
Inclusion Criteria

Positive for any one or more of the following:

  • All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and/or regular use of alcohol)
  • Clinical signs/symptoms (non-healing ulcers, white/ red/red & white patches in the mouth, restriction of mouth opening and swelling of the neck)
  • All individuals aged above 40 irrespective of habit/oral lesions
Exclusion Criteria
  • Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer
  • Under treatment for tuberculosis or suffering from any acute illness/ debilitating systemic disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Participants from VaranasimHealthParticipants will be recruited from Varanasi.
Primary Outcome Measures
NameTimeMethod
Comparison of mHealth with conventional oral cancer screeningUp to 5 years

To compare the efficacy of conventional screening with mHealth in identification of oral potentially malignant disorders (OPMDs) / oral cancer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center (All protocol activites)

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath